Skip to main content
. 2021 Feb 22;5(5):2000115. doi: 10.1002/gch2.202000115

Figure 5.

Figure 5

Nano‐based approaches against SARS‐CoV‐2 reviewed: A) docking interactions between FDA‐approved IONPs with spike RBD od SARS‐CoV‐2; B) functionalized CNTs with target functions; C) FET‐sensor with graphene sheets conjugated to SARS‐CoV‐2 spike antibody; D) pulmonary drug delivery system using NLCs to treat lung infected by SARS‐CoV‐2.